Guide to public health measures to reduce the impact of influenza pandemics in Europe – ‘The ECDC Menu’
This document presents a menu of possible public measures to be taken during influenza pandemics, giving public health and scientific information on what is known or can be said about their likely effectiveness, costs (direct and indirect), acceptability, public expectations and other more practical considerations. The ‘ECDC Menu’ aims to help EU Member States and institutions, individually or collectively, decide which measures they will apply.
No association found between pandemic influenza vaccination and Guillain-Barre Syndrome in EuropeArchived
Due to an association that was observed in the United States between a swine-flu based human influenza vaccine developed in 1976 and the disease acute polyneuropathy Guillain-Barré syndrome (GBS) (1,2), GBS was one of the adverse events that was monitored in Europe and North America (3) following the 2009 influenza pandemic vaccination campaigns.
ERS Training Course: Acute respiratory pandemics: how to plan and manage
This practical course covered outbreak investigation, pandemic planning, recent developments in respiratory pathogen biology and therapy, and focused around two practical scenarios in which participants could gain experience in managing an acute epidemic.
WHO Guidance for Surveillance during an Influenza Pandemic
This guidance is an update to an earlier document “Global surveillance during an influenza pandemic”, published in April 2009. It takes the lesions learned from the 2009 influenza pandemic into consideration and focuses on the key surveillance components needed during an influenza pandemic. The purpose of the updated guidance is to outline the surveillance strategies and essential data requirements that Member States can use throughout the course of an influenza pandemic to ensure informed risk management decisions in pandemic response and fulfilment of IHR (2005) core capacity requirements.
WHO Europe: Influenza
WHO/Europe aim to reduce influenza-related morbidity and mortality by strengthening virological and epidemiological surveillance for mild and severe influenza; using surveillance data to estimate the burden of influenza in order to prioritize national influenza vaccination programmes; and maintaining and strengthening pandemic preparedness activities at the national level. WHO/Europe also monitors the emergence of other respiratory pathogens that have the potential to spread among humans. These include coronaviruses, which cause a range of illnesses from severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) to the common cold.
Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.
WHO online training courses: Preparing for pandemics - fighting against influenza threats
Every few decades a new, and potentially deadly, influenza virus emerges and spreads worldwide. These events – influenza pandemics – are a threat all countries need to prepare for. The Preparing for pandemics channel brings together courses on various aspects of preparedness, including surveillance, public health measures and risk communication during a pandemic. You can learn the basic epidemiology and virology of influenza. You can learn the differences (and similarities) between zoonotic influenza, seasonal influenza and pandemic influenza. And you can get informed about how WHO, Member States, industry and other stakeholders work together in the Pandemic Influenza Preparedness (PIP) Framework.
Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010)
Hanquet, G., van Damme, P., Brasseur, D., de Cuyper, X., Gregor, S., Holmberg, M., Martin, R., Molnar, Z., Pompa, M.G., Snacken, R., van der Se, M., van Ranst, M., Wirtz, A., Neels, P.
Assessment of human influenza pandemic scenarios in Europe
Napoli, C., Fabiani, M., Rizzo, C., Barral, M., Oxford, J., Cohen, J.M., Niddam, L., Goryński, P., Pistol, A., Lionis, C., Bri, S., Nicoll, A., Penttinen, P., Gauci, C., Bounekkar, A., Bonnevay, S., Beresniak, A.